Late-Onset Proteinuria After Antithymocyte Globulin Induction and De Novo Sirolimus Monotherapy in Kidney Transplant Recipients

被引:2
|
作者
Thomusch, Oliver [1 ]
Tittelbach-Helmrich, Dietlind [1 ]
Seifert, Gabriel [1 ]
Pisarski, Przemyslaw [1 ]
机构
[1] Univ Freiburg, Dept Gen & Visceral Surg, D-79106 Freiburg, Germany
关键词
IMMUNOSUPPRESSION; CAMPATH-1H;
D O I
10.1097/TP.0b013e3182366423
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:E62 / E63
页数:2
相关论文
共 50 条
  • [21] The Benefit of Sirolimus Maintenance Immunosuppression and Rabbit Antithymocyte Globulin Induction in Liver Transplant Recipients That Develop Acute Kidney Injury in the Early Postoperative Period
    Duhart, Benjamin T., Jr.
    Ally, Winston A.
    Krauss, Amy G.
    Hudson, Joanna Q.
    Eason, James D.
    Rao, Vinaya
    Vanatta, Jason M.
    JOURNAL OF TRANSPLANTATION, 2015, 2015
  • [22] An Evaluation of De Novo Sirolimus or Tacrolimus Maintenance Immunosuppression on Renal Function in Orthotopic Liver Transplant Recipients Receiving Rabbit Antithymocyte Globulin Induction with a Primary Disease of Hepatitis C.
    Ally, Winston
    Duhart, Benjamin, Jr.
    Krauss, Amy
    Vanatta, Jason
    Mya, Maung
    Nezakatgoo, N.
    Eason, James
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 351 - 351
  • [23] Efficacy and Safety of Extended-Duration Inpatient-to-Outpatient Rabbit Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients: 6-Month Outcomes
    Trofe-Clark, Jennifer
    Reese, Peter P.
    Patel, Hina J.
    Jakobowski, Diane
    Goral, Simin
    Doll, Stacey L.
    Abt, Peter L.
    Bloom, Roy D.
    TRANSPLANTATION, 2012, 94 (05) : 506 - 512
  • [24] Sirolimus-Based Regimens Provide Comparable Long-Term Outcomes to Tacrolimus/Mycophenolate Mofetil in High-Risk De Novo Kidney Transplant Recipients Receiving Rabbit Antithymocyte Globulin Induction.
    Centeno, A.
    Duhart, B., Jr.
    Krauss, A.
    Patel, S.
    Rao, V.
    Eason, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 318 - 318
  • [25] Using Sirolimus and Rabbit Antithymocyte Globulin Induction to Amend Renal Dysfunction after Liver Transplant.
    Duhart, B.
    Ally, W.
    Krauss, A.
    Eason, J.
    Dryn, O.
    Rao, V.
    Nair, S.
    Vanatta, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 682 - 682
  • [26] Using Sirolimus and Rabbit Antithymocyte Globulin Induction to Amend Renal Dysfunction after Liver Transplant.
    Duhart, B.
    Ally, W.
    Krauss, A.
    Eason, J.
    Dryn, O.
    Rao, V.
    Nair, S.
    Vanatta, J.
    TRANSPLANTATION, 2014, 98 : 682 - 682
  • [27] Decreased Long-Term Survival with Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients.
    Bajjoka, I.
    Yaldo, A.
    Crombez, C.
    Abouljoud, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 329 - 329
  • [28] Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
    Lam, Ngan N.
    Jeong, Rachel
    Quinn, Robert R.
    Ravani, Pietro
    Xiao, Huiling
    McAdams-DeMarco, Mara
    Axelrod, David A.
    Schnitzler, Mark A.
    Snyder, Jon J.
    Lentine, Krista L.
    TRANSPLANTATION DIRECT, 2021, 7 (08): : E736
  • [29] Risk Factors for Late-Onset Cytomegalovirus Infection or Disease in Kidney Transplant Recipients
    Jamal, Alainna J.
    Husain, Shahid
    Li, Yanhong
    Famure, Olusegun
    Kim, S. Joseph
    TRANSPLANTATION, 2014, 97 (05) : 569 - 575
  • [30] Bimonthly viral monitoring for late-onset cytomegalovirus infection in kidney transplant recipients
    Melgarejo, Ivy
    Jorgensen, Dana
    Hariharan, Sundaram
    Puttarajappa, Chethan M.
    CLINICAL TRANSPLANTATION, 2021, 35 (05)